James Fingeroot Associate Litigation James represents technology and life sciences companies in a broad range of litigation matters.
Publications Pump-and-Dumpers Take Their Lumps: Influencer Liability Catches the Eye of Federal Regulators December 20, 2022
Publications SEC Adopts Rule Amendments to Provide Enhanced Disclosure of Rule 10b5-1 Plans and Insider Trading December 20, 2022
Publications Federal Circuit Denies Request to Block Disclosure of Litigation Funding Information December 13, 2022
Publications The Long Arm of the Lanham Act? Supreme Court to Consider Foreign Reach of US Law November 15, 2022
Experience Fenwick Represents Royalty Pharma in Acquisition of Royalty Interest in siRNA Drug Olpasiran from Arrowhead Pharmaceuticals in Deal Totaling Up to $410M November 9, 2022
